PLOS GeneticsGeneticsPeer-reviewed journal article
Dissection of a complex disease susceptibility region using a Bayesian stochastic search approach to fine mapping
Chris WallaceiD, Antony J Cutler, Nikolas Pontikos, Marcin L Pekalski, Oliver S Burren, Jason D Cooper, Arcadio Rubio Garcia, Ricardo C Ferreira, Hui Guo, Neil M WalkeriD, Deborah J Smyth, Stephen S RichiD, Suna Onengut-Gumuscu, Stephen S Sawcer, Maria Ban, Sylvia Richardson, John Todd, Linda Wicker
Abstract
Identification of candidate causal variants in regions associated with risk of common diseases is complicated by linkage disequilibrium (LD) and multiple association signals. Nonetheless, accurate maps of these variants are needed, both to fully exploit detailed cell specific chromatin annotation data to highlight disease causal mechanisms and cells, and for design of the functional studies that will ultimately be required to confirm causal mechanisms. We adapted a Bayesian evolutionary stochastic search algorithm to the fine mapping problem, and demonstrated its improved performance over conventional stepwise and regularised regression through simulation studies. We then applied it to fine map the established multiple sclerosis (MS) and type 1 diabetes (T1D) associations in the IL-2RA (CD25) gene region. For T1D, both stepwise and stochastic search approaches identified four T1D association signals, with the major effect tagged by the single nucleotide polymorphism, rs12722496. In contrast, for MS, the stochastic search found two distinct competing models: a single candidate causal variant, tagged by rs2104286 and reported previously using stepwise analysis; and a more complex model with two association signals, one of which was tagged by the major T1D associated rs12722496 and the other by rs56382813. There is low to moderate LD between rs2104286 and both rs12722496 and rs56382813 (r2 [~=] 0.3) and our two SNP model could not be recovered through a forward stepwise search after conditioning on rs2104286. Both signals in the two variant model for MS affect CD25 expression on distinct subpopulations of CD4+ T cells, which are key cells in the autoimmune process. The results support a shared causal variant for T1D and MS. Our study illustrates the benefit of using a purposely designed model search strategy for fine mapping and the advantage of combining disease and protein expression data.
- organism: human
- assay: GWAS summary statistics
- research focus: fine-mapping
- approach: Bayesian inference
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sharing information between related diseases using Bayesian joint fine mapping increases accuracy and identifies novel associations in six immune mediated diseases
Jennifer L. Asimit, Daniel B. Rainbow, … Chris Wallace·Nature CommunicationsPeer-reviewed·Jul 19, 2019
- Fine-mapping identifies causal variants for RA and T1D in DNASE1L3, SIRPG, MEG3, TNFAIP3 and CD28/CTLA4 loci
Harm-Jan Westra, Marta Martínez‐Bonet, … Soumya Raychaudhuri·Nature GeneticsPeer-reviewed·Sep 11, 2018
- Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes
Catherine C. Robertson, Jamie R. J. Inshaw, … Stephen S. Rich·Nature GeneticsPeer-reviewed·Jun 14, 2021
- Statistical Colocalization of Genetic Risk Variants for Related Autoimmune Diseases in the Context of Common Controls
Mary D Fortune, Hui Guo, … Chris Wallace·Nature GeneticsPeer-reviewed·Jun 8, 2015
- Enhanced genetic analysis of type 1 diabetes by selecting variants on both effect size and significance, and by integration with autoimmune thyroid disease
Daniel J. M. Crouch, Jamie R. J. Inshaw, … John A. Todd·bioRxiv·Feb 5, 2021
- Identifying Causal Variants by Fine Mapping Across Multiple Studies
Nathan LaPierre, Kodi Taraszka, … Eleazar Eskin·PLoS GeneticsPeer-reviewed·Sep 20, 2021